Novonesis A/S Class B's next confirmed earnings release is scheduled for November 5, 2026.
| Earnings Date | 11/5/2026 |
As of June 30, 2026, Novonesis A/S Class B has 465.56M shares outstanding.
| Shares Outstanding | 465.56M |
As of June 30, 2026, Novonesis A/S Class B maintains a current ratio of 1.74, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.74 |
| Quick Ratio | 0.26 |
| Debt / Equity | 27.51 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 11,376.25 |
Over the twelve months ended June 30, 2026, Novonesis A/S Class B recorded 2.75B in income tax expense.
| Income Tax | 2.75B |
As of June 30, 2026, Novonesis A/S Class B holds 6.26B in cash and equivalents against 61.25B in total debt, resulting in a net debt position of 50.35B. Total book value stands at 222.66B, with working capital of 17.64B providing operational flexibility.
| Cash & Cash Equivalents | 6.26B |
| Total Debt | 61.25B |
| Net Debt | 50.35B |
| Equity (Book Value) | 222.66B |
| Book Value Per Share | 478.26 |
| Working Capital | 17.64B |
These figures cover the twelve months ended June 30, 2026.
| Capital Expenditures | -8.84B |
Over the twelve months ended June 30, 2026, Novonesis A/S Class B paid dividends of 11.40 per share.
| Dividend Per Share | 11.40 |
Novonesis A/S Class B's most recent stock split took place on November 28, 2011 with a 1:5 split ratio.
| Last Split Date | 11/28/2011 |
| Split Ratio | 1:5 |
Already premium?